ArticlePDF Available

Thymoma: a fatal case report of recurring pneumonia from Tanzania

Authors:

Abstract and Figures

Unlabelled: Thymomas present either concurrently with myasthenia gravis, with local pressure symptoms, or asymptomatically as a mediastinal mass. Due to its variable presentation, the incidence is low, as not all cases would be identified. Thymomas can present with a rare entity of combined T-cell and B-cell immunodeficiency in adults. Thymectomy is the most important prognostic factor, including preventing autoimmune manifestations of thymoma, but immunodeficiency may persist after thymectomy. Case presentation: The authors report a case of thymoma with evidence of immunodeficiency, manifesting as recurrent pneumonia and respiratory distress in an HIV-seronegative 62-year-old man with a suspected diagnosis 3 years before admission. During his bouts of pneumonia, blood cultures revealed methicillin-resistant Staphylococcus aureus, which was initially treated with vancomycin and then with clindamycin. Although hypogammaglobulinemia was not established in our low-resource setting, there was a reduced CD4-cell count with an abnormal CD4/CD8 ratio. The patient responded well to the first course of antibiotics. However, the second attempt was unsuccessful, which led to his demise. Conclusion: Clinicians should be aware that thymoma can cause immunodeficiency. Clinical suspicion should be raised in patients who present with recurrent infections, particularly in thymoma cases with adult-onset immunodeficiency.
Content may be subject to copyright.
Thymoma: a fatal case report of recurring
pneumonia from Tanzania
Abid M. Sadiq, MMeda,e,*, Ruvimbo R. Mukamuri, MDc, Eugenie M. Kamabu, MDe, Faustini C. Kimondo, MDa,
Adnan M. Sadiq, MMedd,e, Gilbert Z. Nkya, MMedb,e
Introduction and importance: Thymomas present either concurrently with myasthenia gravis, with local pressure symptoms, or
asymptomatically as a mediastinal mass. Due to its variable presentation, the incidence is low, as not all cases would be identied.
Thymomas can present with a rare entity of combined T-cell and B-cell immunodeciency in adults. Thymectomy is the most
important prognostic factor, including preventing autoimmune manifestations of thymoma, but immunodeciency may persist after
thymectomy.
Case presentation: The authors report a case of thymoma with evidence of immunodeciency, manifesting as recurrent
pneumonia and respiratory distress in an HIV-seronegative 62-year-old man with a suspected diagnosis 3 years before admission.
During his bouts of pneumonia, blood cultures revealed methicillin-resistant Staphylococcus aureus, which was initially treated with
vancomycin and then with clindamycin. Although hypogammaglobulinemia was not established in our low-resource setting, there
was a reduced CD4-cell count with an abnormal CD4/CD8 ratio. The patient responded well to the rst course of antibiotics.
However, the second attempt was unsuccessful, which led to his demise.
Conclusion: Clinicians should be aware that thymoma can cause immunodeciency. Clinical suspicion should be raised in patients
who present with recurrent infections, particularly in thymoma cases with adult-onset immunodeciency.
Keywords: MRSA, pneumonia, ARDS, thymoma, case report, Tanzania
Introduction
Thymomas are rare mediastinal tumors that occur primarily in
the fourth to the seventh decade of life, with male and female
incidences being comparable
[1,2]
. Thymomas present either
concurrently with myasthenia gravis, with local pressure
symptoms, or asymptomatically as a mediastinal mass on chest
radiography
[2]
. Thymomas can be classied as benign or
malignant based on the degree of capsular invasion. Because of
the variable presentation, the incidence would likely be low, as
not all cases would be identied.
With a thymoma incidence of 0.19 and 0.17 per 100 000
population in the United States and Europe, respectively
[3]
,
the incidence in Africa is unknown. We present the case of a
62-year-old man who died as a result of acute respiratory distress
syndrome, a mediastinal mass, and a recurrent methicillin-
resistant Staphylococcus aureus (MRSA) infection.
The main purpose of this case described here is to report a case
of recurrent pneumonia caused by MRSA in an immunodecient
man with a mediastinal mass, which is a rare association.
This case report has been submitted in accordance with the
Surgical CAse REport (SCARE) guideline criteria 2020
[4]
.
Case presentation
A 62-year-old male presented with 3 years of central chest pain
and a productive cough for 1 year, which were associated with
difculty breathing and chest tightness. He came from a low
socioeconomic family and worked as a peasant farmer. Three
years before admission, he was found to have a mediastinal mass
but decided not to proceed with any therapy. Over the past year,
he had been using over-the-counter cough medications and
antibiotics that did not relieve his symptoms. He progressively
worsened with time and was referred to our center. Apart from
occasional alcohol consumption, there was no signicant social
or familial medical history.
HIGHLIGHTS
Thymomas are rare mediastinal tumors with low incidence
but a fatal outcome if untreated.
Methicillin-resistant Staphylococcus aureus infection is
uncommon in Goods syndrome.
Suspect immunodeciency in patients with recurrent infec-
tions and a mediastinal mass.
Departments of
a
Internal Medicine,
b
Pathology,
c
Surgery,
d
Radiology, Kilimanjaro
Christian Medical Centre and
e
Faculty of Medicine, Kilimanjaro Christian Medical
University College, Moshi, Tanzania
Sponsorships or competing interests that may be relevant to content are disclosed at
the end of this article.
Published online 28 March 2023
*Corresponding author. Address: Department of Internal Medicine, Kilimanjaro
Christian Medical Centre, P.O. Box 3010, Moshi, Tanzania. E-mail address: abid.
physician@gmail.com (A.M. Sadiq).
Received 4 October 2022; Accepted 12 February 2023
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. This is an
open access article distributed under the Creative Commons Attribution-
NoDerivatives License 4.0, which allows for redistribution, commercial and non-
commercial, as long as it is passed along unchanged and in whole, with credit to the
author.
Annals of Medicine & Surgery (2023) 85:10181021
http://dx.doi.org/10.1097/MS9.0000000000000300
Case Report
1018
On examination, he was conscious, afebrile with a temperature
of 36.9°C, dyspneic at rest with oxygen saturation at 85%,
needing oxygen, with grade 2 nger clubbing, but no lower limb
edema. His blood pressure was 98/68 mm Hg, and his pulse rate
was 92 bpm. With reduced symmetrical chest expansion, bilateral
crepitations, and reduced breath sounds bilaterally, it was
suggested that he was in respiratory failure.
His chest radiography showed features of a large mediastinal
mass and bilateral ground-glass opacities (Fig. 1A). A rapid
antigen test for severe acute respiratory syndrome coronavirus 2
was negative. The serology for HIV was negative. His hemato-
logical investigations revealed a leukocyte count of 5.0 ×10
9
/l
with normocytic anemia of 9.1 g/dl and an elevated erythrocyte
sedimentation rate of 48 mm/h. His biochemical investigations
revealed lactate of 2.8, alanine transaminase of 388.8 U/l,
aspartate transaminase of 80.7 U/l, amylase of 80 U/l, and
creatinine of 130 µmol/l.
He was started on intravenous ceftriaxone 1 g once daily until
his blood culture results revealed MRSA, which was sensitive to
vancomycin. The patient was switched to intravenous vanco-
mycin 1 g three times daily. He improved clinically as his
respiratory distress resolved, but was still dependent on low-ow
oxygen.
Noncontrasted computed tomography of the chest revealed an
anterior mediastinal mass measuring 7 cm (Fig. 2), and a biopsy
was taken, which revealed a tumor with mixed cellularity, having
both spindle and epithelioid cells, suggesting a differential of
thymoma or sarcoma. Immunohistochemistry revealed a pan-
cytokeratin-positive and terminal deoxynucleotidyl transferase
(TdT)-negative type A thymoma (Fig. 3). According to the
MasaokaKoga classication, the thymoma was stage IIB. His
CD4 was 407 cells/µl with a CD4/CD8 ratio of 0.8.
Surgical and oncological teams were consulted, and tumor
excision surgery was arranged. However, he started to have
difculty breathing again while in the ward. His repeat full blood
count revealed a leukocyte count of 3.1 ×10
9
/l and normocytic
anemia of 8.3 g/dl. A repeat rapid antigen test for severe acute
respiratory syndrome coronavirus 2 was negative. A control chest
radiography revealed acute respiratory distress syndrome (Fig. 1B),
and he was started on intravenous piperacillin-tazobactam 4.5 g
thrice daily. A repeat blood culture grew MRSA with a different
antimicrobial sensitivity pattern, specically to clindamycin. The
patient was switched to intravenous clindamycin 600 mg every 6 h.
A blood sample for immunoglobulin G was sent outside the
hospital, which revealed him to have hypogammaglobulinemia of
397 mg/dl (normal 6001600 mg/dl). However, his clinical
condition deteriorated,and he developed septic shock, which led to
his death.
Discussion
Patients with thymoma present with several syndromes, generally
autoimmune conditions, compared with local symptoms
[5]
.
Abnormal regulation of lymphocytes in the thymus gland can result
in immunodeciency or autoimmunity, causing myasthenia gravis,
redcellaplasia,orGoods syndrome. In our case, we suspect that
our patient had immunodeciency, which led to recurrent MRSA
infection and respiratory distress, which led to his demise.
Since its rst description in 1954, Goods syndrome is a rare,
adult-onset, acquired immunodeciency in thymoma with
reduced to no B cells, a low CD4 T-cell count, an abnormal CD4:
CD8 T-cell ratio, and hypogammaglobulinemia
[6]
. The patho-
genesis of Goods syndrome is still not known, as the literature
suggests that bone marrow abnormalities, autoimmunity,
and T-cell abnormalities play major roles
[7]
. Respiratory tract
infections are the hallmark of Goods syndrome due to defects
in cell-mediated immunity and B-cell deciency, causing
opportunistic infections.
Figure 1. Posterior anterior chest radiography (A) shows a left anterior mediastinal mass overlying the left hilum and left cardiac border. Hazy ground-glass opacities
are seen in both lung elds. Control chest radiography (B) shows an increase in ground-glass opacities and inltrates in both lung elds, in keeping with acute
respiratory distress syndrome. The left anterior mediastinal mass remained unchanged.
Sadiq et al. Annals of Medicine & Surgery (2023)
1019
Patients with Goods syndrome are susceptible to various
infections, including encapsulated bacteria (Haemophilus,
Pseudomonas,Klebsiella, and Streptococcus), fungi (Candida,
Pneumocystis jirovecii), viral (Cytomegalovirus), and protozoal
(Giardia) infections
[8]
. However, S. aureus is not commonly
identied in Goods syndrome.
In our case, the patient presented with respiratory distress, which
mayhavebeencausedbyaMRSAinfection. Due to his immuno-
deciency, the infection may have led to severe inammation of the
lungs. However, thymomas also cause dyspnea, particularly when
they cause compression of the trachea, superior vena cava
syndrome, phrenic nerve paralysis, and myasthenia gravis
[9]
.
The spindle cells of thymoma with pan-cytokeratin are prob-
ably either type A or type AB thymoma. However, the presence of
a TdT-positive lymphoid population in a spindle cell thymoma is
probably a type AB thymoma
[10]
. Most TdT-negative thymomas
are either type A or type B3. Because of the negative TdT immu-
nohistochemistry and mixed cellularity of the tumor, our patient
was most likely suffering from a type A thymoma. In type A
thymoma, neuroendocrine tumors, paraganglioma, and synovial
sarcomas should be considered in the differential diagnosis.
Although no association has been found between the types of
thymoma and autoimmune complications, the diagnosis of
hypogammaglobulinemia is seen in relatively equal proportions
[8]
.
Figure 2. Axial (A and B) and coronal (C) noncontrast computed tomography of the chest show a well-dened left anterior mediastinal mass with peripheral
calcication exerting pressure on the main pulmonary trunk on the left upper lobe.
Figure 3. Histopathology shows a thymic tumor exhibiting epithelial islands that are intertwined with bundles of delicate spindle cells (A), which are
pan-cytokeratin-positive (B), and TdT-negative (C).
Sadiq et al. Annals of Medicine & Surgery (2023) Annals of Medicine & Surgery
1020
However, most types of thymoma with Goodssyndromeare
benign and are characterized as spindle cell types
[6]
.
The treatment of thymoma is based on staging, but surgical
resection is the most important prognostic factor. The specic
treatment of Goods syndrome includes high-dose intravenous
immunoglobulin to improve the humoral immune response and
prevent opportunistic infections. Thymectomy prevents auto-
immune manifestations of thymoma, but reports suggest that
hypogammaglobulinemia persists after thymectomy
[6]
.
Conclusion
Goods syndrome should be suspected in patients with acute
respiratory distress syndrome and a mediastinal mass, even in
those presenting with uncommon recurrent infections.
Physicians should be aware of the complications of a thy-
moma, and early recognition and diagnosis are recommended
in any suspicious case.
Ethical approval
Our institution does not require ethical approval for reporting
individual cases or case series.
Consent
Written informed consent was obtained from the patients wife
for the publication of this case report and accompanying images.
A copy of the written consent is available for review by the Editor-
in-Chief of this journal on request.
Sources of funding
There was no funding.
Author contribution
A.S., R.M., E.K., and F.K. were involved with patient manage-
ment and preparation of the manuscript. A.S. reviewed the
inherent literature and edited the manuscript. R.M., F.K., A.S.,
and G.N. were involved with relevant investigations. A.S. and
G.N. provided the images. All authors approved the nal version
of the manuscript.
Conicts of interest disclosure
The authors declare no conicts of interest.
Research registration unique identifying number
(UIN)
1. Name of the registry: NA.
2. Unique identifying number or registration ID: NA.
3. Hyperlink to your specic registration (must be publicly
accessible and will be checked): NA.
Guarantor
Abid M. Sadiq.
Provenance and peer review
Not commissioned, externally peer-reviewed.
References
[1] Markowiak T, Hofmann H-S, Ried M. Classication and staging of
thymoma. J Thorac 2020;12:760712.
[2] Engels EA. Epidemiology of thymoma and associated malignancies.
J Thorac Oncol 2010;5:S2605.
[3] Hsu C-H, Chan JK, Yin C-H, et al. Trends in the incidence of thymoma,
thymic carcinoma, and thymic neuroendocrine tumor in the United
States. PLoS One 2019;14:e0227197.
[4] Agha RA, Franchi T, Sohrabi C, et al. for the SCARE Group. The SCARE
2020 Guideline: updating Consensus Surgical CAse REport (SCARE)
Guidelines. Int J Surg 2020;84:22630.
[5] Scorsetti M, Leo F, Trama A, et al. Thymoma and thymic carcinomas.
Crit Rev Oncol Hematol 2016;99:33250.
[6] Bhargava A, Eisenstadt R, Shih JA, et al. A good case of recurrent
pneumonia. J Investig Med High Impact Case Rep 2018;6:23247096188
0286.
[7] Narahari NK, Gongati PK, Uppin SG, et al. A 66-year-old man with
mediastinal mass and dyspnea. Chest 2016;150:e10915.
[8] Kelesidis T, Yang O. Goods syndrome remains a mystery after 55 years:
a systematic review of the scientic evidence. Clin Immunol 2010;135:
34763.
[9] Minervini F, Kocher GJ. When to suspect a thymoma: clinical point of
view. J Thorac Dis 2020;12:76138.
[10] den Bakker MA, Roden AC, Marx A, et al. Histologic classication of
thymoma: a practical guide for routine cases. J Thorac Oncol 2014;9:
S12530.
Sadiq et al. Annals of Medicine & Surgery (2023)
1021
Article
Full-text available
Human autoantibodies (auto‐Abs) neutralizing type I IFNs were first discovered in a woman with disseminated shingles and were described by Ion Gresser from 1981 to 1984. They have since been found in patients with diverse conditions and are even used as a diagnostic criterion in patients with autoimmune polyendocrinopathy syndrome type 1 (APS‐1). However, their apparent lack of association with viral diseases, including shingles, led to wide acceptance of the conclusion that they had no pathological consequences. This perception began to change in 2020, when they were found to underlie about 15% of cases of critical COVID‐19 pneumonia. They have since been shown to underlie other severe viral diseases, including 5%, 20%, and 40% of cases of critical influenza pneumonia, critical MERS pneumonia, and West Nile virus encephalitis, respectively. They also seem to be associated with shingles in various settings. These auto‐Abs are present in all age groups of the general population, but their frequency increases with age to reach at least 5% in the elderly. We estimate that at least 100 million people worldwide carry auto‐Abs neutralizing type I IFNs. Here, we briefly review the history of the study of these auto‐Abs, focusing particularly on their known causes and consequences.
Article
Full-text available
The appropriate therapy and prognosis of patients with thymic malignancies is decisively influenced by the local extent and dissemination of the tumor. For this reason, a staging system that reflects these factors is essential. Mainly the Masaoka-Koga classification, which was introduced in 1994, has been applied for this purpose. The rarity of thymic malignancies makes it difficult not only to establish internationally standardized diagnostics and treatment, but also to progress staging. Besides, efforts were made to adapt the classification into a tumor-node-metastasis-based (TNM) system for standardization with the staging of other tumor entities. The 2017 published 8th edition of the TNM Classification of Malignant Tumors introduced several adjustments based on a proposal of the International Association for the Study of Lung Cancer (IASLC) and the International Thymic Malignancy Interest Group (ITMIG). Compared to the Masaoka-Koga classification, surgically good resectable tumor involvements like pericardium, mediastinal fat or mediastinal pleura have been shifted to lower stages. Thus, even more than in Masaoka-Koga classification, tumors are basically divided into completely resectable and thus surgically treatable tumors (stage I, II, IIIA) and advanced stages (stage IIIB, IVA and IVB) that require multimodal therapy.
Article
Full-text available
Introduction: The SCARE Guidelines were first published in 2016 and were last updated in 2018. They provide a structure for reporting surgical case reports and are used and endorsed by authors, journal editors and reviewers, in order to increase robustness and transparency in reporting surgical cases. They must be kept up to date in order to drive forwards reporting quality. As such, we have updated these guidelines via a DELPHI consensus exercise. Methods: The updated guidelines were produced via a DELPHI consensus exercise. Members were invited from the previous DELPHI group, as well as editorial board member and peer reviewers of the International Journal of Surgery Case Reports. The expert group completed an online survey to indicate their agreement with proposed changes to the checklist items. Results: 54 surgical experts agreed to participate and 53 (98%) completed the survey. The responses and suggested modifications were incorporated to the 2018 guideline. There was a high degree of agreement amongst the SCARE Group, with all SCARE Items receiving over 70% scores 7-9. Conclusion: A DELPHI consensus exercise was completed, and an updated and improved SCARE Checklist is now presented.
Article
Full-text available
The thymus plays a crucial role in the development of immune system, regulating the maturation, selection and migration of T lymphocytes. Alterations in lymphatic content and structure of the thymus are observed in many autoimmune diseases. Moreover, changes of the epithelial component may cause the development of thymic tumours. Thymoma is a rare epithelial tumor of the anterior mediastinal compartment with a wide spectrum of clinical presentations. The causes of thymoma are still unknown and several hypotheses have been formulated. Thymomas show a variable course causing, frequently, a prolonged clinical history. The presence of metastasis at the time of diagnosis is very uncommon. Even if about 30% of the patients with thymoma are asymptomatic, they may have local symptoms (such as cough, pain, hoarseness, and dyspnea) or paraneoplastic disorders. The role of immune system in the pathogenesis of these tumors and related paraneoplastic syndromes is not completely clear. A clinical diagnosis, especially if the first manifestation is a thymoma-associated paraneoplastic disease, is not always easy and should be supported by an appropriate imaging in order to guide the proper management for each patient. In this article, we would like to give an overview of the local and systemic clinical manifestations, which can be found in patients affected by thymoma
Article
Full-text available
This study aimed to identify the trends in the incidence of thymic cancer, i.e., thymoma, thymic carcinoma, and thymic neuroendocrine tumor, in the United States. Data from the United States Cancer Statistics (USCS) database (2001–2015) and those from the Surveillance, Epidemiology, and End Results (SEER) database (SEER 9 [1973–2015], SEER 13 [1992–2015], and SEER 18 [2000–2015]) were used in this study. All incidences were per 100,000 population at risk. The trends in incidence were described as annual percent change (APC) using the Joinpoint regression program. Data from the USCS (2001–2015) database showed an increase in thymic cancer diagnosis with an APC of 4.89% from 2001 to 2006, which is mainly attributed to the significant increase in the incidence of thymoma and thymic carcinoma particularly in women. The incidence of thymic cancer did not increase from 2006 to 2015, which may be attributed to the increase in the diagnosis of thymic carcinoma from 2004 to 2015, with a concomitant decrease in thymoma from 2008 to 2015. Before declining, the age-specific incidence of thymic cancer peaked at ages 70–74 years, with a peak incidence at 1.06 per 100,000 population, and decreased in older age groups. The incidence of thymic cancer was higher in men than in women. Asian/Pacific Islanders had the highest incidence of thymoma, followed by black and then white people. The incidence of thymic carcinoma increased from 2004 to 2015, with a concomitant decrease in thymoma from 2008 to 2015. Asian/Pacific Islanders had the highest incidence of thymoma than other races.
Article
Full-text available
Bordetella bronchiseptica infection is a common cause of pneumonia in animals but rarely causes disease in humans. Additionally, coinfection with Pneumocystis jirovecii is very uncommon and is occasionally seen in patients with acquired immunodeficiency syndrome (AIDS). We report a case of a 61-year-old HIV-negative man, who presented with hypoxic respiratory failure 2 days after completion of systemic intravenous antibiotic treatment for B bronchiseptica. His past medical history was significant for a benign thymoma. The patient was found to be coinfected with B bronchiseptica and P jirovecii. Laboratory results showed panhypogammaglobulinemia and low absolute B- and CD4 T-cells. Therefore, the patient was diagnosed with Good’s syndrome. However, despite treatment with intravenous antibiotics and intravenous immunoglobulin, the patient continued to deteriorate and expired. This patient demonstrates the importance of recognizing this rare immunodeficiency early in order to improve morbidity and mortality. Furthermore, this case highlights the importance of early immunoglobulin screening in the presence of asymptomatic thymoma.
Article
A 66-year-old man presented with dry cough and shortness of breath on exertion of 6 months' duration. There were no complaints of fever and hemoptysis. His history was significant for recurrent episodes of respiratory tract infections over the previous 4 years. He had also had episodes of recurrent otitis media and pus discharge from the left ear for 3 years, with progressive loss of hearing. There was no history of recurrent skin infections or diarrhea. He was treated symptomatically with antibiotics by local general practitioners. He was a nonsmoker and did not drink alcohol, and there was no history of environmental or occupational exposure. He had been known to have diabetes for 10 years. He had negative results for the presence of HIV and hepatitis B surface antigen.
Article
Thymomas (Ts) and thymic carcinomas (TCs) are rare tumours of the mediastinum with an incidence rate of 1.7/million per year in Europe. Histological classification is based on rate of non-malignant-appearing thymic epithelial cells and proportions of lymphocytes (A, AB, B1, B2, B3, and C), while staging system concerns localisation of the involved areas. Surgery is the mainstay of treatment with a 10-year survival of 80%, 78%, 75%, and 42% for stages I, II, III and IV, respectively, with an R0 resection. Radiotherapy has a role in selected cases (stage III patients or R1–2 residual) and platinum-based chemotherapy remains the standard of care for patients with advanced disease. A multimodality approach would be advisable when surgery is not recommended. Since molecular aberrations are poorly understood and few responses are reported, targeted therapies are yet being studied. In this review, we describe key aspects of clinical management for Ts and TCs.
Article
hymomas are rare tumors arising from thymic epithelial cells with incidence rates of approximately 2.5 per mil- lion per year. Thymomas are rare before 25 years of age but show a wide age distribution ( 80 years (mean 50-60 years)) with no major sex predilection. Although thymomas are in general indolent neoplasms, all thymomas, irrespective of subtype, are considered malignant. Thymic carcinomas are set apart from thymomas as a diverse group of tumors with overt, often high grade, malignant behavior and are not fur- ther discussed in detail here. Most thymomas are surgically removed, either as a primary intervention or after work-up, which may include a biopsy. This article provides an over- view of issues related to handling, diagnosing, and reporting of both biopsies and surgical specimens of thymomas. Major considerations of the assessment of thymic tumors are accu- rate subtyping and pathological staging, which hinges upon precise pathological management of specimens. Specific, detailed aspects of thymoma diagnosis and specimen handling are described in recent reviews. 1,2 The majority of thymomas may be confidently diagnosed by following fairly straight- forward algorithms as outlined below. However, it is recog- nized that there are cases which defy certain classification; the issues surrounding these cases and how to deal with these, are described in a recent publication. 3
Article
Thymoma is a rare malignancy of unknown etiology. The author examined patterns in thymoma incidence in the US general population using data from Surveillance, Epidemiology, and End Results (SEER) cancer registries. Prior studies concerning the risk of additional malignancies in thymoma patients were reviewed. Based on cancer registry data, the overall incidence of thymoma in the US is 0.13 per 100,000 person-years. Thymoma is exceedingly uncommon in children and young adults, rises in incidence in middle age, and peaks in the seventh decade of life. Thymoma incidence is especially high among Asians and Pacific Islanders in the US. While several studies based at single treatment centers have suggested that thymoma patients have a broadly increased risk for other malignancies, follow up data from US cancer registries support a more limited spectrum of cancer risk. In particular, thymoma patients have a subsequently elevated risk for developing B-cell non-Hodgkin's lymphoma. Based on limited data, thymoma patients may also have an elevated risk for developing soft tissue sarcomas. Thymoma is a rare malignancy. The excess risk for non-Hodgkin's lymphoma is consistent with an effect of immune disturbance arising from the thymoma or its treatment. While descriptive epidemiologic data may yield clues to the etiology of thymoma, large multi-center case-control studies will be required to formally evaluate environmental and genetic risk factors.
Article
Good syndrome (GS) is a rare association of thymoma and immunodeficiency first described more than 50 years ago. However, this syndrome still remains a mystery to clinicians. We systematically reviewed all the clinical, laboratory and immunologic findings from 152 patients with Good syndrome. The syndrome has a worldwide distribution and approximately half of the cases (47%) have been described in Europe. The diagnosis of thymoma preceded the diagnosis of hypogammaglobulinemia, infection, or diarrhea in 42% of patients whereas in 38% of patients the diagnoses were made almost simultaneously within 2 months of each other. We found significant mortality in patients with this syndrome (44.5%). Astute clinical acumen and increased awareness about the clinical and immunological profile of this syndrome may increase early recognition of this syndrome and prevent mortality. Further studies are needed to elucidate this clinical entity.